Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anjeso (IV meloxicam) Preoperative in Total Knee Arthroplasty
NCT03434275Phase 3Completed
- Sponsor
- Baudax Bio
- Start
- Feb 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Anjeso in postoperative pain, sponsored by Baudax Bio. Started Feb 2018; status: completed.
02
Drugs
Anjeso
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03434275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434275.